Sanofi Fights Bid To Combine EpiPen Suits Against Mylan
Sanofi-Aventis U.S. LLC urged the Judicial Panel on Multidistrict Litigation on Friday to deny a request to join its suit against Mylan Inc. over an alleged monopoly of EpiPen sales with...To view the full article, register now.
Already a subscriber? Click here to view full article